首页|基于UHPLC-Q-TOF/MS结合网络药理学与分子对接技术探究益心饮"异病同治"作用机制

基于UHPLC-Q-TOF/MS结合网络药理学与分子对接技术探究益心饮"异病同治"作用机制

扫码查看
目的:根据中医"异病同治"理论,基于UH-PLC-Q-TOF/MS技术、网络药理学、分子对接方法、细胞实验预测益心饮治疗心律失常、心力衰竭、心肌炎的核心靶点及相关信号通路。方法:采用UHPLC-Q-TOF/MS技术,对益心饮的化学成分和给药大鼠入血原形成分进行分析鉴定;并且通过TC-MSP、SwissTargetPrediction等在线数据库获取入血原形成分潜在作用靶点,利用OMIM、Genecard等数据库获取疾病靶点,做Venn图获取交集靶点,并通过STRING11。5数据库构建蛋白质-蛋白质相互作用(PPI)网络,筛选核心靶点,并选用cyto-scape3。9。0构建"疾病-成分-靶点"网络;利用DA-VID数据库对核心靶点进行GO功能和KEGG富集分析,并运用Autodock vina软件进行分子对接验证,并以H9c2细胞对潜在活性成分和靶点进行验证。结果:从益心饮中鉴定得到157个化合物;从大鼠血清中鉴定得到34个化合物,主要包括姜辣素、异甘草素、甘草次酸等化合物,得到139个交集靶点,结合PPI网络筛选得到31个核心靶点,主要含有TNF、IL-6等靶点,KEGG通路富集分析主要涉及TNF信号通路、IL-17信号通路、MAPK信号通路、P13K-Akt信号通路等。选取TNF、IL-6靶点与主要化合物进行分子对接,对接结果均小于-5 kcal/mol。体外细胞实验表明,益心饮能够通过调节TNF、IL-6发挥治疗作用。结论:益心饮主要潜在活性成分可能是异甘草素、甘草次酸、姜辣素、毛蕊异黄酮苷、丹酚酸B,主要通过作用于TNF、IL-6等靶点来调控特定的信号通路,发挥疗效。
Mechanism of Yi-xin-yin oral liquid according to homotherapy for heteropathy theory based on UHPLC-Q-TOF/MS combined with net-work pharmacology and molecular docking techniques
AIM:To predict the core targets and re-lated signaling pathways of Yi-xin-yin oral liquid for the treatment of arrhythmia,heart failure and myo-carditis based on UHPLC-Q-TOF/MS,network phar-macology,molecular docking methods,cell experi-ments,according to the"homotherapy for heterop-athy"theory in traditional Chinese medicine.METH-ODS:UHPLC-Q-TOF/MS was used to analyze and identify the chemical composition of Yi-xin-yin oral liquid Extract and the blood-absorbing components of rats oral administrated with Yi-xin-yin oral liquid extract,which compounds were applied in the data-bases searching for the potential targets(TCMSP,SwissTargetPrediction)and disease targets(OMIM,Genecard).Venn diagram was used for target inter-section,and the subsequent protein-protein interac-tion network obtained core targets by STRING11.5 database,and then construct a"disease-compo-nent-target"network by cytoscape3.9.0.Finally,DA-VID database was used to analysis GO function and KEGG enrichment analysis of core targets,and mo-lecular docking validation was performed using Autodock vina software.And,validated with H9c2 cells for potential active ingredients and targets.RE-SULTS:A total of 156 compounds were identified from Yi-xin-yin Oral Liquid extract;34 compounds were identified from rat serum,including 6-gin-gerol,isoliquiritigenin,glycyrrhizic acid and other compounds,and 139 intersecting targets were ob-tained.The KEGG pathway enrichment analysis mainly involved the TNF signaling pathway,IL-17 sig-naling pathway,MAPK signaling pathway,P13K-Akt signaling pathway and so on.The TNF and IL-6 tar-gets were selected for molecular docking with the main compounds,and the docking results were good(less than-5 kcal/mol).In vitro cellular experi-ments have shown that Yi-xin-yin oral liquid can ex-ert therapeutic effects by regulating TNF and IL-6.CONCLUSION:The main potential active ingredients of Yi-xin-yin oral liquid may be isoliquiritigenin,glyc-yrrhetinic acid,calycosin-7-glucoside,salvianolic ac-id B,and 6-gingerol,which mainly act on TNF,IL-6 and other targets to regulate specific signaling path-ways and exert therapeutic effects.

Yi-xin-yin oral liquidheart failurear-rhythmiamyocarditishomotherapy for heteropa-thyUHPLC-Q-TOF/MSnetwork pharmacologymo-lecular docking

王业健、焦广洋、庞涛、翁楠、高洁、李娟、陈万生、陈卫东、张凤

展开 >

安徽中医药大学药学院,合肥 230012,安徽

海军军医大学第二附属医院药剂科,上海 200003

上海中医药大学中药研究所,上海 201203

沈阳药科大学中药学院,辽宁 110000,沈阳

展开 >

益心饮 心力衰竭 心律失常 心肌炎 异病同治 UHPLC-Q-TOF/MS 网络药理学 分子对接

国家科技部重点研发项目海军军医大学附属长征医院人才建设三年行动计划

2022YFC350170022S21901900

2024

中国临床药理学与治疗学
中国药理学会

中国临床药理学与治疗学

CSTPCD北大核心
影响因子:0.97
ISSN:1009-2501
年,卷(期):2024.29(1)
  • 1
  • 43